Skip to Content

New prophylactic therapy for patients with hemophilia A and B

A new study of patients with hemophilia A and B suggests that monthly prophylactic treatment with fitusiran reduces episodes of bleedings and improves health-related quality of life.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top